Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (82,667)	$ (31,104)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	6,569	4,551
Impairment of long-lived assets and non-cash restructuring	499	827
Loss on extinguishment of debt	375	0
Amortization of deferred financing costs	234	121
Stock-based compensation	12,510	10,562
Provision for inventory write-down	12,191	3,498
Provision for credit losses, net of recoveries	2,361	(482)
Provision for sales returns	4,255	2,307
Provision for warranty expense	(42)	323
Unrealized loss on foreign currency transactions	806	1,318
Subsidiary dissolution	0	(68)
Loss (gain) on disposal of property, plant and equipment	56	(68)
Changes in operating assets and liabilities, excluding effects of acquisition:
Accounts receivable	61,806	(28,207)
Other receivable	(4,196)	(11,577)
Inventories	(30,058)	(50,719)
Contract assets	(183)	1,515
Prepaid expenses and other assets	(2,950)	(4,248)
Accounts payable	(18,729)	58,202
Contract liabilities	(10,221)	5,744
Accrued and other liabilities	6,165	(662)
Net cash used in operating activities	(41,219)	(38,167)
Cash flows from investing activities:
Proceeds from disposal of property, plant and equipment and other assets	1,829	65
Purchases of property, plant and equipment	(1,408)	(2,310)
Acquisition of business, net of cash acquired	0	(22,297)
Net cash provided by (used in) investing activities	421	(24,542)
Cash flows from financing activities:
Proceeds from long-term borrowings	0	25,000
Repayments of long-term borrowings	(24,073)	(313)
Proceeds from short-term borrowings and line of credit, net	11,537	7,000
Repayments of short-term borrowings and line of credit, net	(4,325)	0
Proceeds from related party term loan	36,930	0
Repayments of related party term loan	(12,693)	0
Payments for debt issue costs	(198)	(776)
Payments of contingent consideration	(347)	(558)
Payments for and proceeds from exercise of stock awards and employee stock plan purchases	(259)	485
Net cash provided by financing activities	6,572	30,838
Effect of exchange rate changes on cash, cash equivalents and restricted cash	914	(815)
Net change in cash, cash equivalents and restricted cash	(33,312)	(32,686)
Cash, cash equivalents and restricted cash at beginning of period	38,464	53,639
Cash, cash equivalents and restricted cash at end of period	5,152	20,953
Reconciliation of cash, cash equivalents and restricted cash to condensed consolidated balance sheets
Cash and cash equivalents	4,294	17,861
Restricted cash	710	2,942
Long-term restricted cash	148	150
Cash, cash equivalents and restricted cash	5,152	20,953
Cash paid during the period for:
Interest - bank and trade facilities	2,460	425
Interest - related party	159	0
Income taxes	$ 722	$ 986